|
Foreword |
5 |
|
|
Preface |
6 |
|
|
Contents |
7 |
|
|
Contributors |
11 |
|
|
Overview |
15 |
|
|
APPENDIX |
21 |
|
|
APPENDIX (Continued) |
22 |
|
|
APPENDIX (Continued) |
23 |
|
|
APPENDIX (Continued) |
24 |
|
|
APPENDIX (Continued) |
25 |
|
|
REFERENCES |
26 |
|
|
Assessment of Surveillance Test Performance and Cost |
27 |
|
|
EPIDEMIOLOGICAL PRINCIPLES FOR EVALUATING DIAGNOSTIC TEST PERFORMANCE IN SCREENING FOR DEVICE MALFUNCTION OR INFECTION Overview |
28 |
|
|
DIAGNOSTIC TEST CHARACTERISTICS Validity |
28 |
|
|
LIKELIHOOD RATIOS |
31 |
|
|
REQUIREMENTS FOR ESTABLISHING A SCREENING PROGRAM |
32 |
|
|
RECEIVER OPERATING CHARACTERISTIC CURVE |
32 |
|
|
THRESHOLDS FOR TREATMENT |
33 |
|
|
THRESHOLDS FOR TESTING |
34 |
|
|
ECONOMIC PRINCIPLES OF FOLLOW-UP EVALUATION Overview of Cost Analysis |
36 |
|
|
SUMMARY |
44 |
|
|
REFERENCES |
44 |
|
|
Costs of Follow-Up After Implantation of Prosthetic Devices |
47 |
|
|
METHODS |
48 |
|
|
RESULTS |
49 |
|
|
COMMENT |
57 |
|
|
REFERENCES |
59 |
|
|
Factors That Should Shape Clinical Strategies |
60 |
|
|
ETHICAL AND LEGAL ISSUES |
67 |
|
|
DURATION OF SURVEILLANCE |
68 |
|
|
SECONDARY BENEFITS OF FOLLOW-UP |
68 |
|
|
PRIMARY PREVENTION OF DISEASE |
68 |
|
|
SUMMARY |
71 |
|
|
REFERENCES |
72 |
|
|
A View From the US Food and Drug Administration* |
74 |
|
|
INTRODUCTION |
74 |
|
|
PREMARKET REVIEW Background |
76 |
|
|
POSTMARKET OVERSIGHT Overview |
86 |
|
|
SPECIAL TOPICS Access to Information |
95 |
|
|
REFERENCES |
98 |
|
|
Societal Issues |
101 |
|
|
TECHNOLOGY AND SOCIETY |
101 |
|
|
TECHNOLOGY AND HISTORY |
101 |
|
|
COSTS |
102 |
|
|
MANAGED CARE |
103 |
|
|
IMPLANTED TECHNOLOGY |
104 |
|
|
BREAST IMPLANTS Background |
104 |
|
|
THE BJORK-SHILEY CONVEXO-CONCAVE ARTIFICIAL HEART VALVE Background |
108 |
|
|
COCHLEAR IMPLANTS (40)* Background |
118 |
|
|
THE TOTAL ARTIFICIAL HEART Background |
120 |
|
|
SOCIETAL ISSUES IN IMPLANTED MEDICAL DEVICES |
123 |
|
|
PROFESSIONAL AND CONSUMER MODELS OF HEALTH CARE |
124 |
|
|
REFERENCES |
124 |
|
|
Databases for Studying the Epidemiology of Implanted Medical Devices* |
127 |
|
|
INTRODUCTION |
127 |
|
|
SYSTEMATIC NEW DATA COLLECTION |
128 |
|
|
GATHERING AND SYNTHESIS OF EXISTING PATIENT DATA AND STUDIES |
131 |
|
|
FUTURE OF DATABASES FOR STUDYING THE EPIDEMIOLOGY OF IMPLANTED DEVICES Increasing Technological Sophistication of Patient Data |
139 |
|
|
ACKNOWLEDGMENT |
140 |
|
|
REFERENCES |
140 |
|
|
Tissue Reaction to Prosthetic Materials |
145 |
|
|
INTRODUCTION |
145 |
|
|
MATERIALS USED IN PROSTHESES |
146 |
|
|
MOLECULAR AND CELLULAR EVENTS OF HOMEOSTASIS |
154 |
|
|
HISTOPATHOLOGY OF EXPLANTED PROSTHESES Dental |
159 |
|
|
FUTURE TRENDS IN PROSTHETIC DESIGN |
165 |
|
|
REFERENCES |
165 |
|
|
Prevention of Infection in Prosthetic Devices |
171 |
|
|
INTRODUCTION |
171 |
|
|
GENERAL PRINCIPLES OF INFECTION PREVENTION IN PROSTHETIC DEVICES Preoperative Measures |
173 |
|
|
INDIVIDUAL CHARACTERISTICS OF THE MOST COMMONLY USED PROSTHETIC DEVICES Breast Implants |
176 |
|
|
SUMMARY |
190 |
|
|
REFERENCES |
193 |
|
|
European Counterpoint to Chapter 9 |
198 |
|
|
INTRODUCTION |
198 |
|
|
THE ROLE OF PROPHYLACTIC ANTIBIOTICS |
199 |
|
|
PATIENT FACTORS THAT CONTRIBUTE TO INFECTION OF PROSTHESES |
200 |
|
|
VENTRICULOPERITONEAL SHUNTS |
200 |
|
|
PENILE PROSTHESIS |
202 |
|
|
JOINT PROSTHESES |
204 |
|
|
MESH REPAIRS OF HERNIAS |
206 |
|
|
VASCULAR GRAFTS |
207 |
|
|
BREAST IMPLANTS |
208 |
|
|
PROSTHETIC CARDIAC VALVES |
209 |
|
|
COCHLEAR IMPLANTS |
210 |
|
|
COMMENTS |
212 |
|
|
REFERENCES |
213 |
|
|
Computer Modeling |
216 |
|
|
INTRODUCTION |
216 |
|
|
EXAMPLE 1: A DECISION TREE FOR A DIAGNOSTIC PROBLEM |
217 |
|
|
EXAMPLE 2: A STATE-TRANSITION MODEL FOR A PROGNOSTIC PROBLEM |
217 |
|
|
EXAMPLE 3: A MODEL FOR A FOLLOW-UP SCHEME |
217 |
|
|
DECISION TREES |
217 |
|
|
EXAMPLE 1: BREAST IMPLANTS |
218 |
|
|
STATE-TRANSITION MODELS |
225 |
|
|
EXAMPLE 2: BJÖRK-SHILEY CONVEXO- CONCAVE HEART VALVE PATIENTS |
229 |
|
|
EXAMPLE 3: EVALUATION OF FOLLOW-UP SCHEMES |
232 |
|
|
GENERAL MODELING ISSUES |
234 |
|
|
VALIDITY AND CREDIBILITY |
235 |
|
|
SUMMARY AND CONCLUSION |
237 |
|
|
FURTHER READING |
238 |
|
|
REFERENCES |
238 |
|
|
Breast Prostheses |
241 |
|
|
INTRODUCTION |
241 |
|
|
MAMMOGRAPHY |
252 |
|
|
ULTRASOUND |
253 |
|
|
MAGNETIC RESONANCE IMAGING |
253 |
|
|
COMPUTED TOMOGRAPHY |
254 |
|
|
ENDOSCOPY |
254 |
|
|
CAPSULAR CONTRACTURE |
254 |
|
|
ACKNOWLEDGMENTS |
258 |
|
|
APPENDIX: SUPPORT GROUPS |
258 |
|
|
APPENDIX: SUPPORT GROUPS ( CONTINUED) |
259 |
|
|
REFERENCES |
259 |
|
|
US Counterpoint to Chapter 11 |
265 |
|
|
INTRODUCTION |
265 |
|
|
REFERENCES |
267 |
|
|
European Counterpoint to Chapter 11 |
269 |
|
|
USE OF BREAST IMPLANTS IN THE UNITED KINGDOM |
269 |
|
|
BREAST AUGMENTATION |
271 |
|
|
INFECTION AND BREAST IMPLANTS |
273 |
|
|
CAPSULAR CONTRACTURE |
274 |
|
|
APPENDIX: SOURCES OF ADDITIONAL INFORMATION |
277 |
|
|
REFERENCES |
278 |
|
|
APPENDIX: SOURCES OF ADDITIONAL INFORMATION (Continued) |
278 |
|
|
Prostheses for Hernia Repair |
280 |
|
|
INTRODUCTION |
280 |
|
|
PROSTHETIC FAILURE AND INFECTION |
283 |
|
|
PREVENTIVE MEASURES |
284 |
|
|
REFERENCES |
284 |
|
|
US Counterpoint to Chapter 12 |
286 |
|
|
INGUINAL HERNIA REPAIR |
286 |
|
|
INCISIONAL HERNIA REPAIR |
288 |
|
|
OTHER ABDOMINAL WALL HERNIAS |
290 |
|
|
SUMMARY |
291 |
|
|
REFERENCES |
291 |
|
|
European Counterpoint to Chapter 12 |
293 |
|
|
PROSTHESES FOR HERNIA REPAIR |
293 |
|
|
IMPORTANCE OF PROSTHESIS DESIGN AND QUALITY OF MANUFACTURE |
294 |
|
|
PREVENTIVE MEASURES |
295 |
|
|
REFERENCES |
295 |
|
|
Penile Prostheses |
297 |
|
|
INTRODUCTION |
297 |
|
|
APPENDIX A: ORGANIZATIONS WITH ERECTILE DYSFUNCTION INFORMATION |
305 |
|
|
APPENDIX A: ORGANIZATIONS WITH ERECTILE DYSFUNCTION INFORMATION (Continued) |
306 |
|
|
PROSTATE CANCER SURVIVORS GROUPS: |
306 |
|
|
APPENDIX B: VENDORS OF PENILE IMPLANTS IN THE UNITED STATES |
306 |
|
|
REFERENCES |
306 |
|
|
US Counterpoint to Chapter 13 |
308 |
|
|
INTRODUCTION |
308 |
|
|
REFERENCE |
309 |
|
|
European Counterpoint to Chapter 13 |
310 |
|
|
INTRODUCTION |
310 |
|
|
SAFETY AND OUTCOME |
311 |
|
|
INDICATIONS FOR IMPLANTING PENILE PROSTHESES |
311 |
|
|
PROSTHETIC DESIGN/QUALITY OF MANUFACTURE |
318 |
|
|
APPENDIX: SOURCES OF ADDITIONAL IINFORMATION |
318 |
|
|
REFERENCES |
319 |
|
|
Artificial Urethral Sphincters |
321 |
|
|
INTRODUCTION |
321 |
|
|
PUBLISHED GUIDELINES FOR FOLLOW-UP |
323 |
|
|
DETECTION OF PROSTHETIC FAILURE |
324 |
|
|
DETECTION OF PROGRESSION OF THE DISORDER FOR WHICH THE PROSTHESIS WAS PLACED |
324 |
|
|
DETECTION OF OTHER CONDITIONS OF MEDICAL SIGNIFICANCE |
325 |
|
|
WHAT IS KNOWN ABOUT ACTUAL STRATEGIES OF PRACTICING CLINICIANS? |
325 |
|
|
IMPORTANCE OF PROSTHESIS DESIGN AND QUALITY OF MANUFACTURE |
325 |
|
|
VARIATION IN FOLLOW-UP BY PROSTHETIC TYPE |
326 |
|
|
ARE MULTICENTER PROSPECTIVE TRIALS NEEDED? |
327 |
|
|
APPENDIX: SUPPORT GROUPS FOR PEOPLE WITH CONTINENCE- RELATED PROBLEMS |
328 |
|
|
REFERENCES |
328 |
|
|
US Counterpoint to Chapter 14 |
330 |
|
|
INTRODUCTION |
330 |
|
|
REFERENCE |
331 |
|
|
European Counterpoint to Chapter 14 |
332 |
|
|
FOLLOW-UP |
336 |
|
|
FUTURE RESEARCH |
337 |
|
|
APPENDIX: ADDITIONAL RESOURCES FOR INFORMATION ABOUT ARTIFICIAL URETHRAL SPHINCTERS |
338 |
|
|
REFERENCES |
338 |
|
|
Cerebrospinal Fluid Shunts |
340 |
|
|
HISTORY |
340 |
|
|
EPIDEMIOLOGY |
342 |
|
|
PATHOPHYSIOLOGY |
343 |
|
|
CSF SHUNT HYDRODYNAMICS |
345 |
|
|
SHUNT COMPONENTS AND DESIGN |
347 |
|
|
OPERATIVE PROCEDURES |
351 |
|
|
FOLLOW-UP CARE |
355 |
|
|
DIAGNOSIS AND TREATMENT OF SHUNT COMPLICATIONS |
358 |
|
|
SUPPORT ORGANIZATIONS |
360 |
|
|
APPENDIX: RECOMMENDED HYDROCEPHALUS SUPPORT ORGANIZATIONS |
360 |
|
|
REFERENCES |
361 |
|
|
US Counterpoint to Chapter 15 |
366 |
|
|
INTRODUCTION |
366 |
|
|
APPENDIX: RESOURCES FOR LEARNING MORE ABOUT HYDROCEPHALUS |
368 |
|
|
REFERENCES |
369 |
|
|
European Counterpoint to Chapter 15 |
370 |
|
|
EPIDEMIOLOGY |
370 |
|
|
EVOLUTION OF CLINICAL PRACTICE |
372 |
|
|
FOLLOW-UP MANAGEMENT |
373 |
|
|
DETECTION AND MANAGEMENT OF SHUNT INFECTION |
376 |
|
|
PRIMARY AND SECONDARY PREVENTION |
378 |
|
|
MULTI-INSTITUTION PROSPECTIVE TRIALS |
379 |
|
|
APPENDIX: SUPPORT GROUPS IN EUROPE |
380 |
|
|
REFERENCES |
380 |
|
|
Cochlear Implants |
386 |
|
|
HISTORICAL ASPECTS AND TRENDS |
386 |
|
|
COCHLEAR IMPLANT COMPONENTS AND THEIR FUNCTIONS |
388 |
|
|
CURRENTLY AVAILABLE COCHLEAR IMPLANTS IN THE UNITED STATES |
389 |
|
|
MEDEL (MEDICAL ELECTRONICS) |
394 |
|
|
PERFORMANCE OF DIFFERENT DEVICES |
395 |
|
|
CANDIDACY, PREOPERATIVE PLANNING, AND SURGERY Indication |
396 |
|
|
IMPORTANCE OF PROSTHETIC DESIGN |
398 |
|
|
FOLLOW-UP CONSIDERATIONS |
399 |
|
|
PROGRAMMING STRATEGIES OF PRACTICING CLINICIANS |
400 |
|
|
SPECIAL PATIENT POPULATIONS |
401 |
|
|
EXPECTATIONS AND RECOVERY STAGES |
404 |
|
|
DELAYED COMPLICATIONS |
404 |
|
|
SUPPORT GROUPS |
406 |
|
|
APPENDIX: CONTACT INFORMATION FOR SUPPORT GROUPS |
408 |
|
|
REFERENCES |
409 |
|
|
US Counterpoint to Chapter 16 |
411 |
|
|
RESPONSIBILITY |
411 |
|
|
EARLY PROBLEM DETECTION |
412 |
|
|
LATE PROBLEM DETECTION |
412 |
|
|
SUMMARY |
413 |
|
|
REFERENCES |
414 |
|
|
European Counterpoint to Chapter 16 |
415 |
|
|
INTRODUCTION |
415 |
|
|
PREOPERATIVE ASSESSMENT |
416 |
|
|
REFERENCES |
418 |
|
|
Ossicular Implants |
420 |
|
|
INTRODUCTION |
420 |
|
|
BIOMATERIALS |
421 |
|
|
TYPES OF OSSICULAR PROSTHESES |
422 |
|
|
INDICATIONS FOR IMPLANTS |
422 |
|
|
FOLLOW-UP |
425 |
|
|
DETECTION OF COMPLICATIONS |
425 |
|
|
PROSTHESES FOR STAPES SURGERY IN OTOSCLEROSIS |
426 |
|
|
APPENDIX: WEB SITES FOR FURTHER INFORMATION |
429 |
|
|
REFERENCES |
429 |
|
|
US Counterpoint to Chapter 17 |
431 |
|
|
RESPONSIBILITY |
431 |
|
|
EARLY PROBLEM DETECTION |
432 |
|
|
LATE PROBLEM DETECTION |
432 |
|
|
THINGS TO AVOID |
433 |
|
|
SUMMARY |
434 |
|
|
REFERENCES |
435 |
|
|
European Counterpoint to Chapter 17 |
436 |
|
|
RECONSTRUCTIVE MIDDLE EAR SURGERY |
436 |
|
|
POSTOPERATIVE SURVEILLANCE |
439 |
|
|
REFERENCES |
441 |
|
|
Vascular Prostheses |
443 |
|
|
INTRODUCTION |
443 |
|
|
GENERAL CONSIDERATIONS |
443 |
|
|
CAROTID REVASCULARIZATION |
447 |
|
|
HEMODIALYSIS ACCESS |
451 |
|
|
RENOVASCULAR INTERVENTIONS |
453 |
|
|
MESENTERIC ARTERY REVASCULARIZATION |
455 |
|
|
INTERVENTIONS FOR AORTOILIAC OCCLUSIVE DISEASE |
457 |
|
|
AORTIC ENDOGRAFTS |
460 |
|
|
SURVEILLANCE AFTER PLACEMENT OF AORTIC ENDOGRAFTS |
463 |
|
|
INFRAINGUINAL BYPASS GRAFTS |
466 |
|
|
TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT |
470 |
|
|
SUMMARY |
472 |
|
|
REFERENCES |
473 |
|
|
US Counterpoint to Chapter 18 |
479 |
|
|
INTRODUCTION |
479 |
|
|
European Counterpoint to Chapter 18 |
486 |
|
|
INTRODUCTION |
486 |
|
|
AORTIC AND SUPRAINGUINAL RECONSTRUCTION AND FOLLOW- UP OF ASYMPTOMATIC PATIENTS |
488 |
|
|
INFRAINGUINAL BYPASS AND FOLLOW-UP IN ASYMPTOMATIC PATIENTS |
490 |
|
|
CONCLUSION |
492 |
|
|
REFERENCES |
492 |
|
|
Cardiac Valves |
494 |
|
|
INTRODUCTION |
494 |
|
|
HISTORY OF HEART VALVE PROSTHESES |
495 |
|
|
CLASSIFICATION OF PROSTHETIC HEART VALVES |
496 |
|
|
MANAGEMENT OF THE PATIENT WITH A PROSTHETIC HEART VALVE |
502 |
|
|
CHRONIC ANTICOAGULATION: THROMBOEMBOLIC RISK AND BLEEDING RISK |
508 |
|
|
PROSTHETIC HEART VALVE DYSFUNCTION |
513 |
|
|
EVALUATION AND TREATMENT OF CORONARY HEART DISEASE IN PATIENTS WITH PROSTHETIC VALVES |
522 |
|
|
APPENDIX: RESOURCES FOR PHYSICIANS AND PATIENTS |
523 |
|
|
REFERENCES |
523 |
|
|
US Counterpoint to Chapter 19 |
528 |
|
|
APPENDIX: RESOURCES FOR PHYSICIANS AND PATIENTS |
531 |
|
|
REFERENCES |
531 |
|
|
European Counterpoint to Chapter 19 |
533 |
|
|
CURRENT PRACTICE |
533 |
|
|
FOLLOW-UP AFTER MECHANICAL HEART VALVE REPLACEMENT |
535 |
|
|
MANAGEMENT OF INFECTIONS AND PREVENTION OF PROSTHETIC VALVE ENDOCARDITIS |
535 |
|
|
MANAGEMENT OF ANTICOAGULANTS |
536 |
|
|
REFERENCES |
537 |
|
|
Intravascular Filters and Stents |
538 |
|
|
INTRODUCTION |
538 |
|
|
VENA CAVAL FILTERS |
538 |
|
|
ENDOVASCULAR STENTS |
542 |
|
|
REFERENCES |
545 |
|
|
US Counterpoint to Chapter 20 |
547 |
|
|
REFERENCES |
550 |
|
|
European Counterpoint to Chapter 20 |
552 |
|
|
VENOUS STENTS |
555 |
|
|
COMMENT |
557 |
|
|
APPENDIX: |
559 |
|
|
SPECIALIST |
559 |
|
|
ORGANIZATIONS IN INTERVENTIONAL |
559 |
|
|
RADIOLOGY |
559 |
|
|
REFERENCES |
561 |
|
|
Vascular Access Devices |
565 |
|
|
HISTORY |
565 |
|
|
SHORT-TERM, PERCUTANEOUS, NON- TUNNELED CENTRAL VENOUS CATHETERS |
566 |
|
|
INTERMEDIATE-TERM CENTRAL VENOUS ACCESS DEVICES |
568 |
|
|
LONG-TERM, SILASTIC, TUNNELED, CUFFED RIGHT ATRIAL CATHETERS |
569 |
|
|
LONG-TERM SUBCUTANEOUS VENOUS ACCESS PORTS |
569 |
|
|
IMPLANTABLE INFUSION PUMPS |
573 |
|
|
CVC MAINTENANCE AND SURVEILLANCE FOR COMPLICATIONS |
573 |
|
|
SURVEY OF OHIO SURGEONS WHO IMPLANT VENOUS ACCESS DEVICES |
576 |
|
|
CVC SURVEILLANCE: CONTROVERSIES AND POTENTIAL FUTURE STUDIES Catheter- Associated Infection |
581 |
|
|
Catheter Occlusion |
583 |
|
|
Catheter Damage/Breakage |
584 |
|
|
Venous Thrombosis and Stenosis |
584 |
|
|
CONCLUSION |
587 |
|
|
REFERENCES |
587 |
|
|
US Counterpoint to Chapter 21 |
592 |
|
|
VASCULAR ACCESS DEVICES |
592 |
|
|
REFERENCES |
595 |
|
|
European Counterpoint to Chapter 21 |
597 |
|
|
BACKGROUND |
597 |
|
|
PREVENTION AND TREATMENT OF COMPLICATIONS |
598 |
|
|
SUMMARY |
601 |
|
|
APPENDIX: RESOURCES WITH ADDITIONAL INFORMATION ABOUT VASCULAR ACCESS DEVICES |
603 |
|
|
REFERENCES |
604 |
|
|
Osseointegrated Dental Implants |
606 |
|
|
INTRODUCTION |
606 |
|
|
IMPLANT-SUPPORTED PROSTHESES |
610 |
|
|
TYPICAL CLINICAL RETURN VISIT |
614 |
|
|
APPENDIX: PARTIAL LIST OF IMPLANT MANUFACTURERS AND SUPPORT GROUPSa |
616 |
|
|
REFERENCES |
617 |
|
|
US Counterpoint to Chapter 22 |
622 |
|
|
APPENDIX:SOURCES OF FURTHER INFORMATION ON OSSEOINTEGRATED DENTAL IMPLANTS |
625 |
|
|
REFERENCES |
625 |
|
|
European Counterpoint to Chapter 22 |
627 |
|
|
INTRODUCTION |
627 |
|
|
THE PERI-IMPLANT ENVIRONMENT |
628 |
|
|
PERI-IMPLANTITIS AND BACTERIAL PLAQUE |
628 |
|
|
MECHANICAL COMPLICATIONS |
629 |
|
|
IMPLANT-SUPPORTED PROSTHESES IN THE UNITED KINGDOM |
629 |
|
|
MAINTENANCE OF DENTAL IMPLANTS |
629 |
|
|
Prosthetic Factors |
630 |
|
|
Soft-Tissue Factors |
631 |
|
|
Bone Factors |
631 |
|
|
Oral Hygiene Factors |
631 |
|
|
SUMMARY |
632 |
|
|
REFERENCES |
632 |
|
|
Cardiac Pacemakers |
635 |
|
|
INDICATIONS FOR PACEMAKER THERAPY AND NEED FOR FOLLOW-UP |
635 |
|
|
THE CLINIC VISIT |
638 |
|
|
ENVIRONMENTAL EFFECTS ON PATIENTS WITH PACEMAKERS |
643 |
|
|
REFERENCES |
645 |
|
|
US Counterpoint to Chapter 23 |
647 |
|
|
INTRODUCTION |
647 |
|
|
REFERENCES |
649 |
|
|
European Counterpoint to Chapter 23 |
651 |
|
|
FOLLOW-UP |
652 |
|
|
MODE SELECTION AND PROGRAMMING |
653 |
|
|
NEW DEVELOPMENTS |
655 |
|
|
REFERENCES |
655 |
|
|
Joint Prostheses and Internal Fixation Devices |
657 |
|
|
INTRODUCTION |
657 |
|
|
TYPES OF ORTHOPEDIC BIOMATERIALS |
662 |
|
|
TOTAL JOINT ARTHROPLASTY |
663 |
|
|
DETECTION OF FAILURE OF FRACTURE FIXATION DEVICES |
665 |
|
|
DETECTION OF PROSTHETIC INFECTION |
667 |
|
|
MANAGEMENT OF THE CONDITION FOR WHICH THE IMPLANT WAS INSERTED |
669 |
|
|
PREVENTIVE MEASURES |
671 |
|
|
POSTOPERATIVE FOLLOW-UP |
674 |
|
|
WHAT HEALTH MAINTENANCE MEASURES ARE WARRANTED? |
675 |
|
|
APPENDIX: SUPPORT GROUPS AND PATIENT INFORMATION FOR MUSCULOSKELETAL DISEASES |
676 |
|
|
APPENDIX: SUPPORT GROUPS AND PATIENT INFORMATION FOR MUSCULOSKELETAL DISEASES ( CONTINUED) |
677 |
|
|
REFERENCES |
677 |
|
|
US Counterpoint to Chapter 24 |
681 |
|
|
REFERENCES |
685 |
|
|
European Counterpoint to Chapter 24 |
688 |
|
|
TOTAL JOINT ARTHROPLASTY |
688 |
|
|
TOTAL JOINT ARTHROPLASTY FAILURE |
690 |
|
|
IMPLANTS FOR FRACTURE FIXATION |
690 |
|
|
THROMBOEMBOLIC PROPHYLAXIS |
691 |
|
|
WHAT HEALTH MEASURES ARE WARRANTED? Arthritis and Total Joint Replacements |
692 |
|
|
APPENDIX: SOURCES OF ADDITIONAL INFORMATION |
692 |
|
|
APPENDIX: SOURCES OF ADDITIONAL INFORMATION (CONTINUED) |
693 |
|
|
REFERENCES |
693 |
|
|
Index |
695 |
|